This website uses cookies. By using the site you are agreeing to our Privacy Policy.



Fujifilm to reinforce its medical equipment business in China, subscribing to Yestar Healthcare Holdings' third-party share allocation

November 30, 2018

FUJIFILM Corporation (President: Kenji Sukeno) has today signed an agreement with Yestar Healthcare Holdings Company Limited (hereinafter “Yestar”) to invest about 6 billion yen in the company by subscribing to third-party allocation of its new shares. After completing the required investment procedures, Fujifilm will acquire 9.56% of the company's shares issued. The Yestar Group handles processing and marketing of Fujifilm's medical X-ray films, photographic products, and industrial films in China. Through this investment, Fujifilm aims to reinforce a comprehensive business partnership with Yestar Group and further expand its business in the Chinese market, which continues to make economic growth with the nation's 1.3-billion population.

Since establishment, the Yestar Group has expanded business as the agency for Fujifilm's photographic products in the Chinese market. It became Fujifilm's exclusive agency for color photographic papers in the Chinese market in 2013, distributing Fujifilm products across China's photographic market. It entered into the medical field, commencing to process and market Fujifilm's medical X-ray films in 2010. The Yestar Group has continued to broaden its scope of business to include medical equipment and other products, boosting its presence in China's healthcare market.

Through this investment, Fujifilm is reinforcing its partnership with Yestar Group especially in the field of medical equipment business. Fujifilm and the Yestar Group will accelerate offering a wide range of Fujifilm's products and solutions across China. Fujifilm also plans to explore the possibility of working with Yestar Group to jointly develop products specifically designed for the Chinese market.

By providing products and solutions optimized for diverse market needs, Fujifilm will continue to contribute to further improving the quality and efficiency of medical care, maintaining and boosting human health and enhancing the quality of life.

<Yestar's overview>

Company name Yestar Healthcare Holdings Company Limited
Representative James Hartono (CEO)
Establishment February 1, 2012
* Listed on the Hong Kong Stock Exchange on October 11, 2013
Paid-in capital 54.48 million Hong Kong dollars (approx. 800 million yen)
Net sales 3,927 million RMB in 2017 (approx. 66.7 billion yen)
Business activities Medical-related business (processing and marketing medical X-ray films and marketing in-vitro diagnostics)
Non-medical business (processing and marketing imaging products)

For inquiries on information in this media release, contact:

Media Contact:
FUJIFILM Corporation
Corporate Communications Division
TEL :+81-3-6271-2000